Paul Tudor Jones's ADMA Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 65,751 shares of ADMA Biologics, Inc. (ADMA) worth $963,910, representing 0.00% of the portfolio. First purchased in 2020-Q1, this long-term strategic position has been held for 23 quarters.
Based on 13F filings, Paul Tudor Jones has maintained a strategic position in ADMA, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2023, adding 146,866 shares. Largest reduction occurred in Q2 2024, reducing 161,696 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's ADMA Biologics (ADMA) Holding Value Over Time
Track share changes against reported price movement
Quarterly ADMA Biologics (ADMA) Trades by Paul Tudor Jones
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2020 | +94,545 | New Buy | 94,545 | $2.88 |
| Q2 2020 | -74,503 | Reduce 78.80% | 20,042 | $2.94 |
| Q3 2020 | -20,042 | Sold Out | 20,042 | $0.00 |
| Q2 2023 | +26,952 | New Buy | 26,952 | $3.69 |
| Q3 2023 | +146,866 | Add 544.92% | 173,818 | $3.58 |
| Q4 2023 | -173,818 | Sold Out | 173,818 | $0.00 |
| Q2 2024 | +12,122 | New Buy | 12,122 | $11.18 |
| Q3 2024 | -1,377 | Reduce 11.36% | 10,745 | $19.99 |
| Q4 2024 | +11,869 | Add 110.46% | 22,614 | $17.15 |
| Q1 2025 | -22,614 | Sold Out | 22,614 | $0.00 |
| Q3 2025 | +65,751 | New Buy | 65,751 | $14.66 |
Paul Tudor Jones's ADMA Biologics Investment FAQs
Paul Tudor Jones first purchased ADMA Biologics, Inc. (ADMA) in Q1 2020, acquiring 94,545 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held ADMA Biologics, Inc. (ADMA) for 23 quarters since Q1 2020. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones's largest addition to ADMA Biologics, Inc. (ADMA) was in Q3 2023, adding 173,818 shares worth $622,268. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 65,751 shares of ADMA Biologics, Inc. (ADMA), valued at approximately $963,910. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, ADMA Biologics, Inc. (ADMA) represents approximately 0.00% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones's peak holding in ADMA Biologics, Inc. (ADMA) was 173,818 shares, as reported at the end of Q3 2023. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.